Breaking

Study on COVID-19 Herbal Drug Complete

The drug which was tested on more than 100 patients at Mulago National Referral Hospital was being promoted as having antiviral, anti-inflammatory and immunological properties and that it will help in the cure of many other infections apart from COVID-19.
Dr. Monica Musenero

Audio 1

A study in which researchers were assessing the efficacy of a herbal drug code-named UBV – 01N is complete.

Dr Monica Musenero, the Minister for Science, Technology and Innovation who was hesitant to divulge results of the study which was launched glamorously by President Yoweri Museveni in January says they tried what they refer to as a cure in animals and later tested it in humans and that the release of these results only awaits a presidential launch.

//Cue in: “We have several…    

Cue out: “… in the hospital”. // 

The drug which was tested on more than 100 patients at Mulago National Referral Hospital was being promoted as having antiviral, anti-inflammatory and immunological properties and that it will help in the cure of many other infections apart from COVID-19.

 

Musenero who is currently on the spot over allegations of misuse of funds meant for the development of COVID-19 related solutions said before the studies, the properties in this cure have worked for people in the communities of Tooro and Teso where some of the raw materials used were picked from.

At the time of the study launch, however, Uganda was at the end of the first wave and scientists reported to have slowed down for lack of participants. Initially, they had planned to involve up to 128 participants in Mulago before going to other facilities across the country. They had planned that the study would be completed within six months. 

This problem, Musenero says was solved in the second wave when critically sick people crowded hospitals. 

Meanwhile, this is not the only therapeutics study that has taken place. The other that involved testing the effectiveness of blood plasma of recovered COVID-19 patients to treat active cases never made it through clinical trials.

To date, Uganda has recorded a cumulative 126,714 infections where 3,231 have died.

     

Images 1

Entities

Keywords